scholarly article | Q13442814 |
P50 | author | Frits Rosendaal | Q16319080 |
Magnus Palmblad | Q37837343 | ||
Andrew Percy | Q56473887 | ||
Yassene Mohammed | Q57248905 | ||
Christoph H Borchers | Q87654817 | ||
P2093 | author name string | Juncong Yang | |
Bart J van Vlijmen | |||
P2860 | cites work | Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS) | Q28681060 |
Hemostatic Abnormalities in Malignancy, a Prospective Study of One Hundred Eight Patients: Part I. Coagulation Studies | Q33462127 | ||
Venous thrombosis: a multicausal disease | Q33597786 | ||
Pathophysiology of the thrombophilic state in the cancer patient | Q33651715 | ||
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma | Q33794491 | ||
Mass spectrometry in high-throughput clinical biomarker assays: multiple reaction monitoring. | Q34377410 | ||
Levels of coagulation factors and venous thromboembolism | Q35152274 | ||
Hemostatic alterations in cancer patients | Q35477688 | ||
Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry | Q37618631 | ||
Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach | Q37623655 | ||
Hematological issues in critically ill patients with cancer. | Q37640330 | ||
The prethrombotic state in cancer | Q37915323 | ||
PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study. | Q40541385 | ||
Qualis-SIS: automated standard curve generation and quality assessment for multiplexed targeted quantitative proteomic experiments with labeled standards | Q41642517 | ||
Malignancies, prothrombotic mutations, and the risk of venous thrombosis | Q45249091 | ||
Absolute quantitation of proteins in human blood by multiplexed multiple reaction monitoring mass spectrometry. | Q45931723 | ||
PeptidePicker: a scientific workflow with web interface for selecting appropriate peptides for targeted proteomics experiments. | Q46901204 | ||
Advances in multiplexed MRM-based protein biomarker quantitation toward clinical utility. | Q50873210 | ||
Multiplexed MRM with Internal Standards for Cerebrospinal Fluid Candidate Protein Biomarker Quantitation. | Q51075854 | ||
A standardized kit for automated quantitative assessment of candidate protein biomarkers in human plasma. | Q53182929 | ||
Proteomics meets the scientific method. | Q55056925 | ||
Method of the Year 2012 | Q56636660 | ||
Abnormalities of blood coagulation tests in patients with cancer | Q69436777 | ||
Hemostatic abnormalities in untreated cancer: incidence and correlation with thrombotic and hemorrhagic complications | Q69449455 | ||
Mass spectrometry-based targeted proteomics | Q86520329 | ||
P433 | issue | 15 | |
P921 | main subject | thrombosis | Q261327 |
P304 | page(s) | 1080-1087 | |
P577 | publication date | 2017-06-20 | |
P1476 | title | Multiplexed targeted proteomic assay to assess coagulation factor concentrations and thrombosis-associated cancer | |
P478 | volume | 1 |
Search more.